NCT01931683View on ClinicalTrials.gov

Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Drug Usage
Interventions
DRUG

remifentanil

The concentration of remifentanil was determined by modified Dixon's up-and-down method, starting from 1.0 ng/ml (0.2 ng/ml as a step size)

DEVICE

laryngeal mask airway (LMA)

LMA was removed when the patients opened their eyes, and spontaneous respiration and adequate tidal volume and ventilatory frequency were confirmed

Trial Locations (1)

443-721

Ajou University School of Medicine, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT01931683 - Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA) | Biotech Hunter | Biotech Hunter